Lam Research Rises 2.74% on 880M Volume Hits 101st in Market Activity as Analysts and Institutions Back Growth

Generated by AI AgentAinvest Volume Radar
Thursday, Sep 4, 2025 8:13 pm ET1min read
LRCX--
Aime RobotAime Summary

- Lam Research (LRCX) rose 2.74% on Sept. 4 with $880M volume, ranking 101st in market activity, driven by mixed but mostly positive analyst sentiment (20 'Buy' vs. 6 'Hold').

- Despite Morgan Stanley's 'Underweight' downgrade to $92, firms like Raymond James and Citigroup raised targets to $113, with Barclays and Goldman Sachs offering $83 and $115 estimates.

- Q2 earnings exceeded estimates (EPS $1.33 vs. $1.21) and revenue jumped 33.6% to $5.17B, while institutional investors increased stakes by 1-14% in Q2.

- Strong financials (29.07% net margin, 0.38 debt-to-equity) and backtesting suggest 16.1% upside, though volatility remains due to a 52-week high of $108.02 and beta of 1.76.

Lam Research (LRCX) rose 2.74% on Sept. 4, with a trading volume of $880 million, ranking 101st in market activity. Analysts highlighted mixed but generally positive sentiment, with 20 “Buy” ratings and six “Hold” ratings, translating to an average price target of $107.22. Despite a downgraded “Underweight” call from Morgan StanleyMS--, which cut its target price to $92 from $94, firms like Raymond James and CitigroupC-- raised their estimates, with the latter setting a $113 target and a “Buy” rating. BarclaysBCS-- and Goldman SachsGS-- also entered the fray, offering $83 and $115 targets, respectively.

The company’s Q2 earnings report fueled optimism, with EPS of $1.33 exceeding estimates by $0.12 and revenue jumping 33.6% year-over-year to $5.17 billion. Institutional investors increased stakes, including Vanguard Group, JPMorgan ChaseJPM--, and State StreetSTT-- Corp, collectively boosting holdings by 1-14% in Q2. This aligns with Lam’s strong financials, including a 29.07% net margin and a debt-to-equity ratio of 0.38.

Backtesting results indicate a 16.1% potential upside from current levels based on mean analyst targets. However, the stock faces near-term volatility, with a 52-week high of $108.02 and a beta of 1.76 reflecting sensitivity to market swings. Analysts remain divided, balancing bullish revenue growth with caution over short-term risks.

Hunt down the stocks with explosive trading volume.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet